These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1819792)

  • 1. [Results of treatment with plasmapheresis in myasthenic crisis and severe polyneuropathy].
    Usnarska-Zubkiewicz L; Bilińska M; Gruszka E
    Pol Arch Med Wewn; 1991 Dec; 86(6):416-9. PubMed ID: 1819792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchange in the management of acute polyradiculopathy and myasthenic crisis (plasma exchange in neurological disorders).
    Devathasan G; Goh CN; Kueh YK; Ong YW; Wong PK
    Ann Acad Med Singap; 1984 Jul; 13(3):538-41. PubMed ID: 6517522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange in neurology.
    Uldry PA; Steck AJ
    Curr Stud Hematol Blood Transfus; 1990; (57):167-83. PubMed ID: 2272200
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasmapheresis in neurology -- personal experience].
    Załeska B; Domzał T; Korsak J
    Neurol Neurochir Pol; 1994; 28(2):167-74. PubMed ID: 8047226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma-exchange in neurological diseases.
    Valbonesi M; Garelli S; Montani F; Mosconi L; Beltramelli A; Zerbi D; Sardella M
    Ric Clin Lab; 1983; 13(1):75-84. PubMed ID: 6857098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical approach to therapeutic apheresis in the management of inflammatory dysimmune polyneuropathies.
    Valbonesi M; Montani F; Mosconi L; Zerbi D; Beltramelli A; Florio G
    Haematologia (Budap); 1985; 18(1):33-43. PubMed ID: 3996945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic plasma exchange for neuroimmunological disorders].
    Shibuya N
    No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute respiratory failure in patients with Guillain-Barré syndrome and myasthenic crisis treated with plasmapheresis in the intensive care unit.
    Szczeklik W; Jankowski M; Wegrzyn W; Królikowski W; Zwolińska G; Mitka I; Seczyńska B; Nizankowski R
    Pol Arch Med Wewn; 2008 Apr; 118(4):239-42. PubMed ID: 18575425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmapheresis in patients with myasthenia gravis].
    Konishi T
    Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmapheresis in neuromuscular diseases. Personal cases].
    Affuso R; Dimonte D; Pagliarulo R; Serlenga L; Simone IL; Specchio LM; Lamberti P
    Acta Neurol (Napoli); 1989; 11(2-3):200-10. PubMed ID: 2782116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmapheresis combined with lymphocytapheresis and cytotoxic drugs as a therapeutic modality in neuroimmunological diseases.
    Valbonesi M; Montani F; Florio G; Zerbi D; Beltramelli A
    Ital J Neurol Sci; 1984 Mar; 5(1):35-40. PubMed ID: 6329999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with plasmapheresis in 153 neurologic patients.
    Dau PC; Miller RG; Denys EH
    Int J Artif Organs; 1982 Jan; 5(1):37-46. PubMed ID: 7068264
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurologic indications for therapeutic plasma exchange: 2011 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2012; 27(3):138-45. PubMed ID: 22522566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenic crisis. Response to plasmapheresis following failure of intravenous gamma-globulin.
    Stricker RB; Kwiatkowska BJ; Habis JA; Kiprov DD
    Arch Neurol; 1993 Aug; 50(8):837-40. PubMed ID: 8352670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and the clinical application. k. Nervous system diseases].
    Sato T; Utsumi H; Kagamihara Y
    Nihon Rinsho; 1984 Aug; 42(8):1908-13. PubMed ID: 6513058
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasmapheresis in neurological diseases].
    Oikarinen R
    Duodecim; 1990; 106(7):553-4. PubMed ID: 1670211
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasmapheresis treatment in neurologic diseases--a report of experiences].
    Hendrich A; Zschenderlein R; Röseler E; Michalik M; Precht K
    Psychiatr Neurol Med Psychol Beih; 1988; 40():79-83. PubMed ID: 3146088
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmapheresis for neurological disorders.
    Schröder A; Linker RA; Gold R
    Expert Rev Neurother; 2009 Sep; 9(9):1331-9. PubMed ID: 19769448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré Syndrome.
    Lizarraga AA; Lizarraga KJ; Benatar M
    Semin Neurol; 2016 Dec; 36(6):615-624. PubMed ID: 27907966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.